Kbc Group Nv Enzo Biochem Inc Transaction History

Kbc Group Nv

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$2.57 - $3.68 $120,106 - $171,981	-46,734 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$3.01 - $4.0 $89,354 - $118,744	29,686 Added 174.13%	46,734 $168,000
Q2 2019 Jul 30, 2019	BUY	$2.79 - $4.31 $26,778 - $41,367	9,598 Added 128.83%	17,048 $0
Q1 2018 May 09, 2018	SELL	$5.43 - $8.36 $113,275 - $174,397	-20,861 Reduced 73.69%	7,450 $0
Q3 2017 Nov 13, 2017	BUY	$10.45 - $11.44 $295,849 - $323,877	28,311	28,311 $0

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $33.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.